|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Solving surface plasmon resonances and near field in metallic nanostructures:Green’s matrix method and its applications显示文摘With the development of nanotechnology,many new optical phenomena in nanoscale have been demonstrated.Through the coupling of optical waves and collective oscillations of free electrons in metallic nanostructures,surface plasmon polaritons can be excited accompanying a strong near field enhancement that decays in a subwavelength scale,which have potential applications in the surface-enhanced Raman scattering,biosensor,optical communication,solar cells,and nonlinear optical frequency mixing.In the present article,we review the Green's matrix method for solving the surface plasmon resonances and near field in arbitrarily shaped nanostructures and in binary metallic nanostructures.Using this method,we design the plasmonic nanostructures whose resonances are tunable from the visible to near-infrared,study the interplay of plasmon resonances,and propose a new way to control plasmonic resonances in binary metallic nanostructures. | GU Ying LI Jia MARTIN Olivier J F GONG QiHuang | 2010 | Chinese Science Bulletin2010，55，24： | 3 |
| 2 | 关节镜下肩袖钙化灶去除率的相关性研究显示文摘目的分析关节镜下治疗肩袖钙化性肌腱炎中钙化灶去除率与术后功能恢复的关系及其影响因素。方法回顾性研究1999年1月~2005年3月接受肩关节镜治疗的77例(81侧)肩袖钙化性肌腱炎患者的临床资料,分别记录其肩袖钙化灶的部位、X线片上的类型、大小和手术前后的功能评分,并分析相互之间的相关性。结果术后患者平均随访7.2个月,肩关节功能按Constant和Murley的评分绝对值自术前的61.3分提高至术后最后随访时79.6分,钙化灶的平均去除率为83%。术前钙化灶的大小与肩关节术前功能不相关。钙化灶的去除率与患者的年龄、钙化灶的类型、大小不相关。术后肩关节功能的改善与钙化灶的去除率无相关性。但钙化灶的部位影响其去除率及术后功能改善,尤其是冈下肌的钙化灶去除比较困难且功能改善不显著。结论肩关节镜治疗肩袖钙化性肌腱炎疗效良好。钙化灶的去除率与肩关节功能不相关,但钙化灶的清除率与钙化灶的部位有关。彻底清除钙化灶可避免术后疼痛爆发。 | 陆雄伟 Olivier Verborgt Dominique F Gazielly | 2007 | 中华创伤骨科杂志2007，9，5： | 2 |
| 3 | Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial显示文摘 | David Laharie Arnaud Bourreille Julien Branche Matthieu Allez Yoram Bouhnik Jerome Filippi Frank Zerbib Guillaume Savoye Maria Nachury Jacques Moreau Jean-Charles Delchier Jacques Cosnes Elena Ricart Olivier Dewit Antonio Lopez-Sanroman Jean-Louis Dupas F | 2012 | The Lancet2012，，9857： | 2 |
| 4 | Local immunotherapy with interleuk in-2 delivered from biodegradable p olymer microspheres combined with interstitial chemotherapy:a novel treatme nt for experimental malignant glioma显示文摘OBJECTIVE:Local delivery of carmustine(BCNU)from biodegradable polymers prolon gs survival against experimental brain tumors.Moreover,paracrine administration of inte rleukin-2(IL-2)has been shown to elicit a potent antitumor immune response and to improve survival in animal brain tumor models.We r eport the use of a novel polymeric mic rosphere delivery vehicle to release IL-2.We demonstr ate both in vitro release of cytokine from the microspheres and histological evidence of the inflammatory response elicited by I L-2released from the microspheres i n the rat brain.These microspheres a re used to deliver IL-2,and biodegradable polymer wafers are used to deliver BCNU,directly at the site of an intracranially implanted glioma in the rat.The two agents administered locally show a s ynergistic effect.METHODS:Fischer 344rats challenged intracranially with 9L gliosarcoma received an intracranial implant of either empty microspheres or microspheres containing IL-2(IL-2MS ).Five days later,animals in each group were randomized to receiv e polymer implants loaded with 0,3.8,or 10%BCNU at the tumor site.RESULTS:Animals that received the combination of IL-2MS a nd 3.8%BCNU polymer(median survival,28.5d )or IL-2MS and 10%BCNU polymer(median survival,45.5d )showed significantly improved surv ival compared with animals that rece ived monotherapy with IL-2microsph eres(median survival,24d ),3.8%BCNU polymer(median survival,24d ),or 10%BCNU polymer(median survival,32.5d ).Control animals had a median survival of 18days.The combination of either 3.8or 10%BCNU polymer with IL-2MS resulted in 7and 25%long-term survivors,respectively.CONCLUSION:By showing synergy of IL-2and BCNU in an animal glioma model and using a reproducible synthetic delivery sy stem for each agent (i.e.,one that did not rely on genetic ally engineered cells or viruses),we hope that the combination of local immunotherapy and chemotherapy can take an important step closer to clinical applic ation in patients with malignant brain | Rhines LD DiMeco F Lawson HC Tyler BM Hanes J Olivi A Brem H | 2003 | 癌症2003，22，7： | 2 |
| 5 | Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: a phase II study显示文摘 | Olivier Rixe Ronald M Bukowski M Dror Michaelson George Wilding Gary R Hudes Oliver Bolte Robert J Motzer Paul Bycott Katherine F Liau James Freddo Peter C Trask Sinil Kim Brian I Rini | 2007 | Lancet Oncology2007，，： | 2 |
| 6 | 转移三角肌肌瓣治疗难修复性肩袖损伤显示文摘目的评价三角肌肌瓣治疗慢性挛缩性难修复性肩袖损伤的长期效果。方法18例患者(20肩)接受三角肌肌瓣转移手术并获得随访,男15例,女3例;年龄40--67岁,平均52-3岁;随访时间9-8~17.2岁,平均13.9年。其中16例患者(17肩)在术后平均47.6个月时接受过一次随访研究。患者均为难修复性慢性肩袖损伤,症状平均持续时间为19.1个月。手术均采用Takagishi描述的Augereau改良术。术后康复理疗持续平均9.4个月。采用Constant功能评分。对肌瓣厚度、肩峰肱骨头间隙和骨关节炎程度进行测定。结果Constant功能评分的绝对值从术前的49.1分改善至末次随访时的71.9分。疼痛的分值从5-3分提高到13.8分,日常生活能力的分值从8.6分增加到17分。运动范围分值从术前30.75分改善到33-3分,主动旋内分值从术前6.95分改善到8.4分。肌肉力量分值从术前4.4分增加到7.6分。16例肩关节的冈上肌力量试验为阳性。三角肌肌瓣的厚度为4.2mm。肩峰肱骨头间隙从术前的6.95mm减小到3.05mm。骨关节炎根据Samilson分型,从术前的0.6期发展成2.0期。结论从短、中期效果来看,对希望重返工作岗位的患者可以考虑采用转移三角肌肌瓣方法治疗,但患者必须忍受较长时间的术前和术后康复理疗期;从长期效果来看,此方法可造成50%的肌瓣断裂和70%的肩关节中、重期的骨关节炎,效果不容乐观。 | 陆雄伟 Olivier Verborgt Dominique F Gazielly | 2007 | 中华骨科杂志2007，27，10： | 2 |
| 7 | Upregulation of β3-adrenoreptors and altered contractile response to inotropic amines in human failing myocardium显示文摘 | Stephane M Lester K Olivier F | 2001 | Circulation2001，103，： | 1 |
| 8 | Occipital lobe epilepsy: electroclinical manifestations, eleetroeortieography, cortical stimulation and outcome in 42 patients treated between 1930 and 1991: surgery of oeeipltal lobe epilepsy显示文摘 | Salanova V Andermann F Olivier A | 1992 | Brain1992，115，： | 1 |
| 9 | Establishment and characterization of ovine blood monocyte-derived cell lines显示文摘 | Olivier M Berthon P Chastang J Cordier G Lantier F | 2001 | Veterinary Immunology and Immunopathology2001，82，34： | 1 |
| 10 | Resistance of tomato line Hawaii7996 to Relastonia solanacearum Pss4 in Taiwan is controlled mainly by a major strain-specific locus 显示文摘 | WANG J F OLIVIER J THOQUEF P | 2000 | Molecular Plant-Microbe Interactions2000，13，1： | 1 |
| 11 | Multimodal nonlinear imaging of the human cornea显示文摘 | Aptel F Olivier N Deniset-Besseau A | 2010 | Invest Ophthalmol Vis Sci2010，51，5： | 1 |
| 12 | Reconciling distance functions and level set显示文摘 | GOMES J OLIVIER F | 2000 | Journal of Visual Communication and Image Representation2000，11，： | 1 |
| 13 | New method for analysing complete denture occlusion using the center of force concept: a clinical report显示文摘 | Olivier F Kang KH Hirayama H | 1998 | J Prosthet Dent1998，80，5： | 1 |
| 14 | Impact of a five-year surveillance of central venous catheter infections in the REACAT intensive care unit network in France显示文摘 | L'HERITEAU F OLIVIER M MAUGAT S | 2007 | J Hosp Infect2007，66，2： | 1 |
| 15 | Mutation detection in the ABCC6 gene and genotype-phenotype analysis in a large international case series affected by pseudoxanthoma elasticum显示文摘 | Ellen G Olivier V Sharon F | 2007 | J Med Genet2007，5，6： | 1 |
| 16 | Genetic causes of bronchiectasis 显示文摘 | Gould C M Freeman A F Olivier K N | 2012 | Clinics in Chest Medicine2012，33，2： | 1 |
| 17 | Dengue 1 virus binding to human hepatoma HepG2 and simian Vero cell surfaces differs显示文摘 | Marianneau P Megret F Olivier R | 1996 | J Gen Virol1996，77，10： | 1 |
| 18 | Metallothionein isoform 2A expression is inducible and protects against ROS-mediated cell death in rotenone-treated HeLa cells显示文摘 | Reinecke F Levanets O Olivier Y | 2006 | B iochem J2006，395，2： | 1 |
| 19 | Complex partial seizures and small posterior temporal or extratemporal structural lesions: surgical management显示文摘 | Fish D Andermann F Olivier A | 1991 | Neurology1991，41，： | 1 |
| 20 | Anthropogenic ocean acidification over the twenty-first century and its impact on calcifying organisms显示文摘 | JAMES C O VICTORIA J F OLIVIER A | 2005 | Nature2005，437，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员